CYCP2-1 Antibody

Basic Research Questions

• What is CYCP2-1 and what is its functional role in plant systems?

CYCP2;1 is a plant-specific cyclin that functions as an integrator between genetic regulation and nutritional signaling. Research has demonstrated that CYCP2;1 is both a direct target of STIMPY transcriptional activation and an early responder to sugar signals in Arabidopsis. Molecular studies have revealed that CYCP2;1 physically interacts with three of the five mitotic CDKs in Arabidopsis and is required for the G2 to M transition during meristem activation .

Unlike mammalian cyclins, CYCP2;1 acts as a permissive control of cell cycle progression during seedling establishment by directly linking genetic control and nutritional cues with the activity of the core cell cycle machinery . This makes it an excellent marker for studying the interface between metabolic status and developmental processes in plants.

• What are the recommended protocols for CYCP2-1 antibody validation?

Effective validation of CYCP2-1 antibodies should follow a multi-step approach:

Required validation steps:

• Use of genetic knockouts (Δcyc3) as negative controls to confirm antibody specificity

• Expression analysis across developmental stages including trophozoite, gametocyte, and ookinete stages, where differential expression has been documented

• Cross-reactivity testing with related cyclins (e.g., CYC1, CYC4) to ensure specificity

• Western blot analysis using protein extracts from both vegetative and reproductive tissues

Validation data table:

Following these validation steps ensures reliable antibody performance in downstream applications .

• What sample preparation techniques optimize CYCP2-1 detection in plant tissues?

For optimal detection of CYCP2-1 in plant tissues, the following methodological considerations are crucial:

• Tissue fixation: For immunohistochemistry applications, use 4% paraformaldehyde in PBS for 1-2 hours at room temperature, followed by ethanol dehydration series.

• Protein extraction:

  • Use non-denaturing lysis buffer containing:

    • 20 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 1 mM EDTA

    • 1% Triton X-100

    • Protease inhibitor cocktail

    • Phosphatase inhibitors (to preserve phosphorylation states)

• Antigen retrieval: For fixed tissues, use citrate buffer (pH 6.0) or TE buffer (pH 9.0) and heat treatment to expose epitopes .

• Dilution recommendations:

  • Western blotting: 1:500-1:2000

  • Immunohistochemistry: 1:20-1:200

  • Immunofluorescence: 1:400-1:1600

These optimized methods significantly improve detection sensitivity while preserving the native conformation of CYCP2-1 protein.

Advanced Research Questions

• How can CYCP2-1 antibodies be effectively used in co-localization studies with cell cycle markers?

Co-localization studies with CYCP2-1 and other cell cycle markers require careful planning and execution:

Recommended approach:

• Multi-channel immunofluorescence protocol:

  • Use primary antibodies raised in different host species (e.g., rabbit anti-CYCP2-1 with mouse anti-CDK)

  • Select secondary antibodies with minimal spectral overlap (e.g., Alexa Fluor 488 and Alexa Fluor 647)

  • Include DAPI staining to visualize nuclear DNA

• Recommended marker combinations:

  • CYCP2-1 with CDK2/CDK1 to study cyclin-kinase complex formation

  • CYCP2-1 with E2F transcription factors to understand G1/S transition regulation

  • CYCP2-1 with histone H3 (phospho S10) to identify mitotic cells

• Image acquisition parameters:

  • Use deconvolution fluorescence imaging for detailed subcellular localization

  • Capture z-stacks at 0.3-0.5 μm intervals

  • Quantify co-localization using Pearson's correlation coefficient

Research shows that CYCP2-1 is uniformly present in both cytoplasm and nucleus in various cell types, with noticeable enrichment in the nucleus of specific cells . This distribution pattern changes during cell cycle progression, making temporal tracking essential.

• What are the critical considerations when using CYCP2-1 antibodies in high-throughput screening approaches?

For high-throughput screening with CYCP2-1 antibodies, researchers should consider:

• Antibody array platforms:

  • ELISA-based antibody arrays with covalently immobilized antibodies on 3D polymer-coated glass slides provide robust quantification

  • Include positive controls (β-actin, GAPDH) and negative controls on each slide

  • Optimize fluorescent detection parameters for signal-to-noise ratio improvement

• Sample processing workflow:

  • Protein extraction with non-denaturing lysis buffer

  • Biotinylation of protein samples

  • Incubation of labeled samples with antibody array

  • Detection by dye-conjugated streptavidin

• Data normalization strategies:

  • Use internal reference proteins like tubulin-α or tubulin-β

  • Apply statistical methods to account for inter-array variability

  • Establish threshold values based on controls to identify significant changes

This approach enables quantitative comparison of CYCP2-1 expression across multiple experimental conditions simultaneously .

• How do post-translational modifications affect CYCP2-1 antibody epitope recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition of CYCP2-1:

• Phosphorylation impacts:

  • Phosphorylation at specific sites (similar to CDK phosphorylation by CDK1-cyclin B1) can mask antibody epitopes

  • Phosphorylation may induce conformational changes affecting antibody binding

  • Use of phosphatase treatment before immunodetection can help distinguish phosphorylation-dependent epitope masking

• Epitope-specific considerations:

  • N-terminal antibodies may be affected by proteolytic processing

  • Internal epitope antibodies provide more consistent detection regardless of terminal modifications

  • C-terminal antibodies may be affected by ubiquitination before protein degradation

• Technical solutions:

  • Use multiple antibodies targeting different epitopes

  • Employ phospho-specific antibodies for detecting specific modified forms

  • Apply Phos-tag SDS-PAGE to separate phosphorylated from non-phosphorylated forms

  • Combine with mass spectrometry to identify novel modification sites

Research has shown that CDK-cyclin interactions are regulated by phosphorylation status, suggesting that CYCP2-1 detection may vary depending on its activity state during the cell cycle .

• What methodological approaches can reveal CYCP2-1 interactions with plant CDKs?

To study CYCP2-1 interactions with plant CDKs, researchers should consider these methodological approaches:

• Co-immunoprecipitation (Co-IP) protocol:

  • Lyse plant tissues in buffer containing:

    • 50 mM Tris-HCl (pH 7.5)

    • 150 mM NaCl

    • 1% NP-40

    • 0.5% sodium deoxycholate

    • Protease inhibitors

  • Immunoprecipitate with anti-CYCP2-1 antibody

  • Analyze precipitated proteins for CDK presence by Western blot

  • Consider sequential IPs to isolate specific complexes

• In vitro kinase assays:

  • Immunoprecipitate CYCP2-1-CDK complexes

  • Use histone H1 as substrate

  • Measure kinase activity using [γ-32P]ATP incorporation

  • Compare activity in different developmental stages

• Yeast two-hybrid confirmation:

  • As demonstrated with KRP proteins in Arabidopsis, Y2H can verify direct interaction between CYCP2-1 and specific CDKs

  • Include both full-length and domain-specific constructs

  • Quantify interaction strength by β-galactosidase assays

Research has shown that plant cyclins like CYCP2-1 can interact with multiple CDKs, but with varying affinities that influence cell cycle control . These methodologies can reveal both the specificity and functional significance of such interactions.

• How can CYCP2-1 antibodies be used to study nutritional and developmental signal integration?

CYCP2-1's role in integrating nutritional and developmental signals makes it an excellent marker for studying these regulatory networks:

• Sugar signaling experimental design:

  • Treat seedlings with varying glucose concentrations (0-6%)

  • Sample at multiple time points (0, 2, 6, 12, 24 hours)

  • Quantify CYCP2-1 protein levels by Western blot

  • Correlate with meristem activation markers

  • Use mutants in sugar signaling pathways (e.g., hexokinase mutants) as controls

• Developmental time course analysis:

  • Track CYCP2-1 levels from seed imbibition through early seedling growth

  • Use immunohistochemistry to visualize spatial distribution in meristematic regions

  • Correlate with cell division rates and meristem size

  • Compare wild-type with STIMPY mutant backgrounds

• Combined approaches:

  • ChIP-seq to identify STIMPY binding to CYCP2-1 promoter

  • RNA-seq to correlate transcriptional changes with protein levels

  • Metabolomic analysis to link carbon availability with CYCP2-1 expression

  • Confocal microscopy with fluorescent reporter lines to track real-time responses

This multifaceted approach can reveal how CYCP2-1 functions as a molecular integrator between nutritional status and developmental programs in plants .

• What controls should be included when using CYCP2-1 antibodies in different experimental systems?

Proper experimental controls are essential when working with CYCP2-1 antibodies:

• Essential negative controls:

  • CYCP2-1 knockout/knockdown plants (e.g., T-DNA insertion lines)

  • Primary antibody omission control

  • Isotype control antibody (same species/isotype, irrelevant specificity)

  • Pre-absorption with immunizing peptide/protein

• Positive controls:

  • Recombinant CYCP2-1 protein at known concentrations

  • Tissue types with validated high expression (e.g., meristematic regions)

  • GFP-tagged CYCP2-1 transgenic lines for parallel detection with anti-GFP antibodies

  • Tissues during growth stages with known high expression

• System-specific controls:

  Experimental System	Specific Controls Required
  In vitro culture	Sugar-starved vs. sugar-supplemented conditions
  Developmental studies	Time-matched samples from multiple growth stages
  Stress responses	Matched unstressed controls
  Transgenic complementation	Multiple independent transgenic lines
  Tissue specificity	Adjacent non-target tissues as internal controls

Including these comprehensive controls ensures reliable interpretation of experimental results and facilitates troubleshooting of unexpected observations .

• How can cyclical immunofluorescence (CyCIF) techniques be applied to study CYCP2-1 localization in complex tissues?

Cyclical immunofluorescence (CyCIF) offers powerful advantages for studying CYCP2-1 in complex plant tissues:

• CyCIF protocol adaptation for plant tissues:

  • Fix tissues in 4% paraformaldehyde

  • Embed in paraffin or prepare frozen sections

  • Perform initial immunostaining with CYCP2-1 antibody

  • Image and record coordinates

  • Chemically inactivate fluorophores (using 0.5% H₂O₂ in sodium borate buffer)

  • Repeat staining with additional antibodies (up to 30+ rounds)

• Multiplexed marker analysis:

  • Combine CYCP2-1 with cell cycle markers (CDKs, other cyclins)

  • Include cell type-specific markers for tissue contextualization

  • Add metabolic sensors to correlate with nutritional status

  • Incorporate developmental markers to establish temporal context

• Advanced analysis approaches:

  • Apply deep learning algorithms for pattern recognition

  • Perform unsupervised clustering to identify cell populations

  • Develop spatial transcriptomics correlations

  • Create 3D reconstructions of expression domains

This approach enables unprecedented multiplexed analysis of CYCP2-1 within its native tissue context, revealing both subcellular localization and cell-type specific regulation patterns that would be impossible to discern with conventional techniques .